PDF《Schedule) Order 2018》

(b) N-{[1-( 环己基甲基)-1H- 吲哚-3- 基]羰基}-3- 甲 基缬氨酸甲酯 ( 通常称为 MDMB-CHMICA);

(c) N-( 金刚烷 -1- 基)-1-(5- 氟戊基 )-1H- 吲唑 -3- 甲酰 胺(通常称为 5F-APINACA 或5F-AKB-48);

(d) 3,4- 二氯 -N-(2- 二甲基氨基 - 环己基 )-N- 甲基 - 苯 甲酰胺 ( 通常称为 U-47700);

(e) N- 甲基-1-( 噻吩-2- 基)丙-2- 胺(通常称为Methiopropamine 或MPA). Explanatory Note This Order amends Part I of the First Schedule to the Dangerous Drugs Ordinance (Cap. 134) in order to impose control on the following substances― (a) Ethyl phenyl(piperidin-2-yl)acetate (commonly known as Ethylphenidate or EPH);

(b) Methyl N-{[1-(cyclohexylmethyl)-1H-indol-3-yl] carbonyl}-3-methylvalinate (commonly known as MDMB-CHMICA);

(c) N-(Adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole- 3-carboxamide (commonly known as 5F-APINACA or 5F-AKB-48);

(d) 3,4-Dichloro-N-(2-dimethylamino-cyclohexyl)-N- methyl-benzamide (commonly known as U-47700);

(e) N-Methyl-1-(thiophen-2-yl)propan-2-amine (commonly known as Methiopropamine or MPA).